NSAM

Technical and Fundamental Factors Point to Shorting Opportunity

Short
AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
Rising wedge to triple top @ 93-94 then bearish confirmation breaking the neckline @85. Also, upside momentum declining as indicated by the RSI and MACD divergence, with MACD crossing the zero line. Political rhetoric by both Democrats and Republicans suggesting government intervention as the solution for combating rising healthcare cost. Also, majority of constituent names have weak fundamentals (e.g., negative PE) and may be first to be discarded in a major downturn for their high-beta speculative nature. VIX also at all time low and a spike in vol could propel name to the downside quite aggressively. Severe short squeeze may be possible along the way (as we saw today) due to very large short interest in the name. But near-term path of least resistance (trend) appear to be down rather than up.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.